High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance

BACKGROUND: The expression profile of high-mobility group box 2 (HMGB2) in patients with glioblastoma multiforme (GBM) and its clinical signature with underlying mechanisms were not fully explored. METHODS: HMGB2 protein levels were measured in 51 GBM patients by immunohistochemical studies. To clar...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Wu, Zhe Bao, Cai, Lin, Lin, Shao Jian, Xiong, Zhen Kun, Lu, Jiang Long, Mao, Ying, Yao, Yu, Zhou, Liang Fu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2013
Aiheet:
Clinical Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3748920/
https://ncbi.nlm.nih.gov/pubmed/23828241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not078
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia